Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)”

44 trials

Showing 20 of 44 results

Not applicableWithdrawnNCT03379025
What this trial is testing

Effects of Electronic Cigarettes in Cigarette Smokers With Mild to Moderate COPD

Who this might be right for
COPDTobacco Use
Massachusetts General Hospital
Testing effectiveness (Phase 2)Ended earlyNCT04441788
What this trial is testing

Assess the Safety, Tolerability, and Efficacy of ION-827359 in Participants With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD) With Chronic Bronchitis (CB)

Who this might be right for
Chronic BronchitisChronic Obstructive Pulmonary Disease
Ionis Pharmaceuticals, Inc. 60
Early research (Phase 1)Active Not RecruitingNCT07116889
What this trial is testing

Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD

Who this might be right for
AsthmaCOPD (Chronic Obstructive Pulmonary Disease)
Generate Biomedicines 156
Testing effectiveness (Phase 2)Study completedNCT02130193
What this trial is testing

Investigation of Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Clinical Efficacy of Oral Danirixin in Symptomatic COPD Subjects With Mild to Moderate Airflow Limitation at Risk for Exacerbations

Who this might be right for
Pulmonary Disease, Chronic Obstructive
GlaxoSmithKline 102
Early research (Phase 1)Study completedNCT05373953
What this trial is testing

Clinical Study to Investigate the Pharmacokinetics, Safety and Tolerability Following Single Administration of CHF6001 in Subjects With Mild, Moderate and Severe Liver Impairment in Comparison With Matched Healthy Control Subjects

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Early research (Phase 1)Study completedNCT01052298
What this trial is testing

Study to Evaluate the Safety and Pharmacokinetics of Inhaled Ciprofloxacin in Patients With Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Disease, Pulmonary
Bayer 25
Large-scale testing (Phase 3)UnknownNCT04536675
What this trial is testing

Effect of Perioperative Bronchodilator in COPD Patients Undergoing Lung Cancer Surgery

Who this might be right for
Chronic Obstructive Pulmonary DiseaseNon Small Cell Lung Cancer
Samsung Medical Center 204
Testing effectiveness (Phase 2)UnknownNCT01486186
What this trial is testing

Effect of Traditional Chinese Medicine on Outcomes in Patients With Mild/Moderate Chronic Obstructive Pulmonary Disease

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Henan University of Traditional Chinese Medicine 504
Testing effectiveness (Phase 2)Study completedNCT03118765
What this trial is testing

Pharmacodynamic and Pharmacokinetic Dose Ranging Study of Tiotropium Bromide Administered Via Inhalation Solution in Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Mild to Moderate Chronic Obstructive Pulmonary Disease (COPD)
Glenmark Specialty S.A. 155
Not applicableStudy completedNCT02660437
What this trial is testing

PCO2 Oscillations During Exercise: Relation to Cerebral Blood Flow and to Cognitive Dysfunction in COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
Schön Klinik Berchtesgadener Land 91
Not applicableWithdrawnNCT00159289
What this trial is testing

Endotoxin and Inflammatory Markers in Healthy Non-Smokers and Current Smokers Including Patients With Chronic Obstructive Pulmonary Disease (COPD)

Who this might be right for
Chronic Obstructive Pulmonary Disease
Imperial College London
Testing effectiveness (Phase 2)Study completedNCT00239278
What this trial is testing

Budesonide / Formoterol in Treatment of Exacerbations of COPD

Who this might be right for
Chronic Obstructive Pulmonary Disease
AstraZeneca 120
Post-approval studies (Phase 4)UnknownNCT04101500
What this trial is testing

Effect of Compound Sodium Chlorate and Aminophylline Tablets on Chronic Obstructive Pulmonary Disease(COPD).

Who this might be right for
Acute Exacerbation of Chronic Obstructive Pulmonary Disease
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 200
Early research (Phase 1)Study completedNCT05431426
What this trial is testing

PK of CHF6001 in Subjects With Mild, Moderate and Severe Renal Impairment vs. Healthy Volunteers

Who this might be right for
Chronic Obstructive Pulmonary Disease
Chiesi Farmaceutici S.p.A. 44
Not applicableLooking for participantsNCT05829083
What this trial is testing

DUET Versus Standard Interface for Hypercapnic COPD Patients

Who this might be right for
COPD ExacerbationHypercapniaCOPD
Larissa University Hospital 50
Post-approval studies (Phase 4)Study completedNCT02579772
What this trial is testing

Effects of N-acetylcysteine on Cardiorespiratory Control in COPD Patients With Mild-to-moderate Airflow Obstruction

Who this might be right for
Pulmonary Disease, Chronic Obstructive
Queen's University 13
Early research (Phase 1)Study completedNCT02040597
What this trial is testing

Investigate the Pharmacokinetics, Safety and Tolerability of CHF 5993 pMDI in Subjects With Renal Impairment.

Who this might be right for
Chronic Obstructive Pulmonary Disease (COPD)
Chiesi Farmaceutici S.p.A. 42
Early research (Phase 1)Study completedNCT00568503
What this trial is testing

Safety, Tolerability and Pharmacodynamics of QAX028 Compared to Open-label Tiotropium Bromide and Placebo in Mild-to-moderate Chronic Obstructive Pulmonary Disease (COPD) Patients.

Who this might be right for
COPD
Novartis 29
Testing effectiveness (Phase 2)Study completedNCT00672802
What this trial is testing

Safety of Ramelteon in Subjects With Mild to Moderate Chronic Obstructive Pulmonary Disease

Who this might be right for
Chronic Obstructive Pulmonary DiseaseCOPD
Takeda 26
Testing effectiveness (Phase 2)Study completedNCT01939587
What this trial is testing

Study to Assess the Efficacy of a Single PBF-680 Oral Administration to Attenuate Adenosine 5'-Monophosphate Challenge-induced Airway Hyperresponsiveness in Mild-to-moderate Asthmatics

Who this might be right for
Asthma
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau 21
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation